Background {#Sec1}
==========

Perthes' disease is an idiopathic osteonecrosis of the hip in childhood. It most commonly affects boys aged 4--8 years \[[@CR1]\]. The highest incidence of Perthes' disease is in Northern Europe, particularly the Northern part of the UK \[[@CR2]\] and Norway \[[@CR3]\]. Perthes' disease generates a susceptibility of the femoral head, to change shape, due to the forces acting across the joint \[[@CR4], [@CR5]\]. These shape changes alter the way that the joint moves, which can cause lifelong pain, functional limitations and accelerate the development of osteoarthritis \[[@CR6]\].

Clinical treatments focus on the prevention of femoral head collapse, restoring the range of motion (ROM) and improving the functional recovery (absence of pain, amount of usual daily activity and sport-related activity) of the children \[[@CR7]\]. Even though there are many published studies investigating the effectiveness of various surgical or non-surgical treatments, there is no consensus for the best management approach in the paediatric orthopaedic community \[[@CR8]\]. In fact, there are no standard outcome methods to assess the success of treatment, which results in difficulties when trying to make comparisons between studies.

The absence of standard outcomes is one of the important pieces of feasibility information required before definitive intervention studies can begin. The development of core outcome sets (COS), popularised through the COMET Initiative, is the approach that has been developed to formulate a set of standardised outcomes particularly for use in clinical research such as randomised controlled trials (RCT) \[[@CR9]\]. COS in clinical trials seek to reduce heterogeneity of the outcomes, reduce bias, improve the accuracy of data interpretation and allow meaningful comparisons between studies facilitating meta-analysis \[[@CR9]\].

Currently, a small number of COS have been developed within orthopaedic surgery, such as for hip fractures \[[@CR10]\] or on generic total joint replacement \[[@CR11]\]. To date, no COS are available to determine the success of interventions used in the treatment of Perthes' disease of the hip in childhood.

Aim and objectives {#Sec2}
==================

Aim {#Sec3}
---

The aim of this study is to develop a COS for Perthes' disease treatment in children, which can be used in clinical and cost effectiveness studies \[[@CR9]\].

Objectives {#Sec4}
----------

Systematically review the current literature to identify outcomes used in previous studies of interventions for Perthes' disease;Identify outcomes important to children and parents through an interview process;Prioritise the outcomes from key stakeholders, such as surgeons, physiotherapists and family doctors using a Delphi survey;Conduct a consensus meeting where the outcome list will be discussed with all stakeholders and parent and child representatives to form the core outcomes list.

Methods/design {#Sec5}
==============

Systematic review {#Sec6}
-----------------

The aims of the systematic review are to identify the primary and secondary outcomes in both operative and non-operative intervention strategies for Perthes' disease. All RCTs, cohort studies and case series that include patients treated for Perthes' disease, irrespective of their treatment type, that report childhood outcomes of the disease, will be included. Following the PICO (Population Intervention Comparison Outcomes) approach, the inclusion criteria are here summarised:Population: Children with Perthes' diseaseIntervention and comparator: any treatmentOutcomes: any outcomes

All studies must involve humans and all studies must be in the English language. This review will be limited to manuscripts in English, which have been published since 1990. The systematic review aims to generate a list of all outcomes measures used in the current literature.

### Selection of studies {#Sec7}

The search strategy will identify all published papers on the management of Perthes' disease. Databases involved in the search will be the Cochrane Library, PubMed and Web of Science. Multiple databases will be used to maximise the sensitivity of the search strategy. The time period searched will be between January 1990 to January 2017.

### Eligibility of studies {#Sec8}

Studies will be selected by two reviewers (DGL and WJL) who will screen all the titles and abstracts. Titles of articles will be reviewed and included or excluded using Rayyan software \[[@CR12]\]. Full text of all the manuscripts that match the inclusion criteria or manuscripts in which the abstract does not give enough information to make a clear decision about their inclusion will be obtained. This process will be documented with the PRISMA \[[@CR13]\] flow diagram.

### Data extraction {#Sec9}

Data from eligible studies will be extracted through the data extraction form (Additional file [1](#MOESM1){ref-type="media"}: Appendix S1). This involves identification of the primary objective, prospective/retrospective data collection, study type, population, number of patients, conservative management, surgical management, primary and secondary outcomes measured, outcome assessment tools, follow-up.

### Data analysis and presentation {#Sec10}

All outcomes reported in eligible studies will be extracted and tabulated with their definition and measurement method(s) and then categorised in domains. To ensure the comprehensiveness of COS, outcomes terms will be assigned to one of the five core domains of the OMERACT \[[@CR14]\] framework, that include the areas that should be covered by outcomes measures in order to ensure an adequate reporting of the results. The five domains of the OMERACT filter 2.0. are divided as: (1) adverse event; (2) life impact; (3) resource use; (4) pathophysiological manifestations; and (5) death. As suggested by Dorman et al. \[[@CR15]\], the additional sixth domain of 'technical considerations', not included in the original OMERACT filter, will be included in order to assess technical or surgical outcomes that surgeons use to quantify successful outcomes. Under this domain will also be assessed the feasibility of use in clinical practice of the reported outcomes \[[@CR16]\]. All six areas, related to the purpose of the review, are listed in Table [1](#Tab1){ref-type="table"}.Table 1Modified OMERACT filter 2.0. core areasCore areaCore domainsExample(s)Adverse eventsAdverse eventsUnintended consequencesLife impactPhysical/Social/Emotional/ Cognitive/Health-Related quality of lifeQuality of life, pain, impact on family, absence from school, participation in sports activities, functional scores -- hip ROM and gait impairmentsResource useEconomic/Hospital/Need for intervention/Social burdenLength of stay, further surgery, physiotherapyPathophysiological manifestationsMusculoskeletalFemoral head collapse, healing process, impingementDeathN/AN/ATechnical considerationsTechnical/Surgical considerationsRadiographic measurement\
Feasibility of use in clinical practice

Identification of key outcomes to patients and parents {#Sec11}
------------------------------------------------------

### Overview {#Sec12}

Patients and parents' opinions will be investigated and integrated in the COS development process through the identification of patient-reported outcomes (PROs) through semi-structured interviews administered to the patients and their parents, in order to assess the life impact of the disease \[[@CR17]\]. Patient involvement is a fundamental step in defining the COS, following the COMET guidelines \[[@CR9]\]. PROs identified through semi-structured interviews will be added to outcome list obtained from the systematic review. The full list will then be submitted for the experts' evaluation through round 1 of the Delphi Survey.

### Interview process {#Sec13}

In order to determine the PROs for children with Perthes' disease, the process will include two stages (Fig. [1](#Fig1){ref-type="fig"}):Parents will be interviewed through a semi-structured interview process;Children, with the help of the parents and/or of the interviewers (if needed), will complete a bespoke booklet to report their PROs. This booklet was initially designed with the help of two families affected by Perthes' disease to ensure that it was sufficient to extract all of the relevant information. The booklet is used as a prompt to develop further discussion with the children.Fig. 1*Schematic* of the interview process

Sample size will ensure insight into a diverse range of parent and child perspectives. We aim to recruit up to 40 participants, 20 with parents and 20 with their child with Perthes' disease. The sample size estimation is based on general qualitative research guidelines \[[@CR18]\] and it will be deemed complete when there will be agreement that saturation is reached, with no new outcome domains generated. The sample will purposively select a range of children aged 5--16 years, both boys and girls, at different stage of the disease (pre or post surgery, or treated with conservative approaches). The aim is to provide a richness in perspectives while remaining feasible within resource constraints. Data representing a variety of perspectives and from a diverse sample help to enhance the credibility of findings by demonstrating that the researcher has sought to present a balanced picture and not favoured one particular viewpoint or perspective \[[@CR19]\]. Participants will be selected from patients attending Alder Hey Children's Hospital Liverpool (UK), from members of the Perthes' Association (UK) and via families known to the International Perthes' Disease Study Group (IPSG).

Inclusion into this part of the study for children (and their parents) are related to the history of Perthes' disease in the child (irrespective of the current stage of disease and treatment method) and the ability to be conversant in English.

### Interview format {#Sec14}

Among parents, a semi-structured interview will be used. Informed consent will be collected from the participants before the interview. The parent(s) of each child will be interviewed in a session that will last approximately 30 min. The interview will comprise a series of open-ended questions on their experiences and impact of the Perthes disease on their everyday life. The interviews aim to collect participants' experience of the disease and the impact of Perthes' disease on their lives, evaluating the daily needs that they have to deal with. The questions will investigate areas such as impact of the disease on patients and related family, the importance of clinical management, the impact of the disease on daily living activities and sport/recreational activities. Thus, based on our pilot work, the interview will be directed to the importance of defining key outcomes in the treatments and identifying possible outcomes in the management of Perthes' disease. In the children's group, a booklet (Additional file [2](#MOESM2){ref-type="media"}: Appendix S2) including questions related to Perthes' disease and its influence in the child daily life, will be completed by each child, with the help of the interviewers where needed. The booklet aims to be a prompt for further discussion involving children and contains questions related to pain, hip mobility, related influence of the disease in the daily activities and effects of the treatment(s), explained through the use of emoji to ensure ease of completion. The final part of the booklet includes a personal description of a recent bad day and good day experienced by the child. This last part will be transcribed in children aged \< 8 years (which will be helped by the interviewers) and recorded as an open-question interview in children aged \> 8 years. The booklet completion process takes no longer than 30 min.

Consultation with the Health Research Authority deemed this study a service evaluation project with no requirement for ethical approval (reference 60/89/81). Informed consent will be assumed if participants agree to fill in the survey. A consent form indicating informed consent will be signed by parents to agree participation in the interview and allow voice recording of the interviews.

### Interview analysis {#Sec15}

All interviews will be recorded and transcribed; then, the transcripts and the recordings will be analysed in line with the qualitative approach following the National Centre for Research Methods guidelines \[[@CR20]\].

The process of analysis of the qualitative data will summarise and define the key outcomes based on the stakeholders' opinion.

Identification of key outcomes to clinicians {#Sec16}
--------------------------------------------

### Overview {#Sec17}

A Delphi survey \[[@CR21]\] (Fig. [2](#Fig2){ref-type="fig"}) will be conducted to identify the key outcomes important to orthopaedic surgeons, GPs and physiotherapists. The Delphi approach is a consensus technique that involves a series of questionnaires administered to target experts in the investigated area, which answer in an anonymous way in order to reduce reciprocal influences and bias \[[@CR21]\].Fig. 2*Schematic* summary of Delphi Survey Process

### Identification of potential outcomes {#Sec18}

A complete list of all the outcomes present in the literature will be made following the approach of the systematic review described in this protocol. Additional outcomes will be included following the PROs obtained by the patients/parents' interviews. Each outcome will be listed both individually and by domain.

### Participants {#Sec19}

Previous studies have indicated that a sample size of at least 20 clinicians is adequate in order to achieve the main goals of COS studies \[[@CR22]\]. Participants will be those with experience of managing children with Perthes' disease. This group of experts will include orthopaedic surgeons, GPs and physiotherapists, including both UK experts and an overseas experts group. The clinicians involved in the study will be selected through the British Society of Children's Orthopaedic Surgery (BSCOS) and the International Perthes' Disease Study Group (IPSG). Participants will be contacted and invited to participate in the survey by email using a bespoke COS Delphi management tool.

### Delphi survey {#Sec20}

The survey will be based on two stages (rounds). Clinicians involved in the study will have a three-week time period to complete each stage of the survey.

### Delphi round 1 {#Sec21}

The electronic data collection form will seek details of participants' demographic data (participant name, clinical role, place of work and contacts), seek the important list of selected outcomes (from the review and the patients/parents' interviews) (to be graded on a score of 1--9 with '1--3 = not relevant'; '4--6 = important but not critical'; and '6--9 = extremely relevant') and will give the possibility to add additional outcomes considered of importance (and related scores) not listed in the list.

### Analysis of Delphi round 1 {#Sec22}

The analysis of the data will summarise the outcomes considered most important. Additional outcomes added by the clinicians will be reviewed by two assessors (DGL and WJL) in order to ensure that they do not refer to outcomes already listed. The number of the invited participants that respond to the survey will also be recorded.

### Delphi round 2 {#Sec23}

At the second stage, participants involved in round 1 of the Delphi survey will be able to see the summary of the data obtained in round 1, asking them to review again the list of outcomes, considering if the outcomes present in the summarised list have to be classified as relevant or not.

Participants that do not respond to round 1 will be excluded in round 2.

### Analysis of Delphi round 2 {#Sec24}

The total number of participants invited to participate and do participate in round 2 will be recorded. The distribution of scores will be summarised. In the summary of the percentage agreement, each individual outcome will be classified as 'consensus in', 'consensus out' or 'no consensus' based on the percentage.

Consensus meeting {#Sec25}
-----------------

The final stage of the study will be based on a consensus meeting between a selected group of clinicians and a selected group of patients/parents (for a total of 24 participants, adhering to the OMERACT guidelines for the consensus meeting structure \[[@CR14]\]).

Before the meeting, the patients/parents group will be able to review the outcomes selected by the clinicians during the Delphi survey and these data will be discussed during the consensus meeting.

### Definition of consensus {#Sec26}

Following the GRADE guidelines \[[@CR23]\], in order to define consensus, outcomes inclusion will be indicated as the agreement by the vast majority (\> 70% of the group) of the 'extremely relevant' (7--9 points range) of the discussed outcomes, with only a minority (\< 15% of the group) of participants that consider it as 'not relevant' (1--3 points range). Consensus for outcomes exclusion will be indicated as the agreement by the vast majority (\> 70% of the group) of the 'not relevant' (1--3 points range) of the discussed outcomes, with only a minority (\< 15% of the group) of participants that consider it as 'extremely relevant' (7--9 points range).

Discussion {#Sec27}
==========

The evaluation of literature on Perthes' disease shows a clear lack of common outcome measures reported among different studies in the literature. This lack of a COS impacts the ability to produce meaningful research and inhibits the ability to compare research findings in order to clearly define the management guidelines for Perthes' disease. Thus, a clear definition and implementation of a COS is required in order to help future researchers identify the primary outcome measures in their studies in order to increase the quality and the clinical application of the results obtained.

Trial status {#Sec28}
============

The systematic review and the patients' recruitment for the interview process is currently ongoing.

Search strategies {#Sec29}
=================

PubMed search strategy: 1 January 1990 to 1 January 2017'Femur Head Necrosis' \[MeSH\]Osteonecrosis \[MeSH\](Perthe\* OR Legg-Calv\*-Perthe\* OR Legg-Perthe\* OR Calv\*-Perthe\*)(Perthe\* AND Legg-Calv\*-Perthe\* AND Legg-Perthe\* AND Calv\*-Perthe\*)(\#1 OR \#2 OR \#3 OR \#4) AND Hip\*(\#5) AND (Child\* OR Infant\*)

Cochrane CENTRAL search strategy: 1 January 1990 to 1 January 2017MeSH descriptor: \[Femur Head Necrosis\] explode all treesMeSH descriptor: \[Osteonecrosis\] explode all trees(TITLE-ABSTRACT-KEYWORDS) Perthe\* OR Legg-Calv\*-Perthe\* OR Legg-Perthe\* OR Calv\*-Perthe\*(TITLE-ABSTRACT-KEYWORDS) Perthe\* AND Legg-Calv\*-Perthe\* AND Legg-Perthe\* AND Calv\*-Perthe\*(TITLE-ABSTRACT-KEYWORDS) (\#3 OR \#4) AND Hip\*(TITLE-ABSTRACT-KEYWORDS) (\#5) AND (Child\* OR Infant\*)

Web of Science search strategy: 1 January 1990 to 1 January 2017(TOPIC) 'Femur Head Necrosis'(TOPIC) Osteonecrosis(TOPIC) Perthe\* OR Legg-Calv\*-Perthe\* OR Legg-Perthe\* OR Calv\*-Perthe(TOPIC) Perthe\* AND Legg-Calv\*-Perthe\* AND Legg-Perthe\* AND Calv\*-Perthe\*(TOPIC) (\#1 OR \#2 OR \#3 OR \#4) AND Hip\*(TOPIC) (\#5) AND (Child\* OR Infant\*)

Additional files
================

 {#Sec30}

Additional file 1:Appendix S1. Systematic review data extraction form. (DOCX 20 kb) Additional file 2:Appendix S2. Children's booklet. (DOCX 242 kb)

BSCOS

:   British Society of Children's Orthopaedic Surgery

COMET

:   Core Outcome Measures in Effectiveness Trials

COS

:   Core outcomes set

GRADE

:   Grading of Recommendations Assessment, Development and Evaluation

IPSG

:   International Perthes' Disease Study Group

OMERCAT

:   Outcome Measures in Rheumatology

PICO

:   Population Intervention Comparison Outcomes

PRISMA

:   Preferred Reporting Items for Systematic Reviews and Meta-Analyses

PRO

:   Patient-reported outcome

ROM

:   Range of motion

RTC

:   Randomised controlled trial
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